{"id":630881,"date":"2025-01-02T11:32:43","date_gmt":"2025-01-02T16:32:43","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=630881"},"modified":"2025-02-19T15:40:43","modified_gmt":"2025-02-19T20:40:43","slug":"victoza-generic-approval","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/news\/victoza-generic-approval\/","title":{"rendered":"FDA approves first generic once-daily GLP-1 medication"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">As <\/span><a href=\"https:\/\/www.singlecare.com\/drug-classes\/glp-1-agonists\"><span style=\"font-weight: 400;\">glucagon-like peptide-1 (GLP-1) receptor agonists<\/span><\/a><span style=\"font-weight: 400;\"> continue to surge in popularity, the\u00a0<\/span><span style=\"font-weight: 400;\">U.S. Food and Drug Administration approved the second generic in this class of medications: liraglutide <\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/victoza\"><span style=\"font-weight: 400;\">(Victoza)<\/span><\/a><span style=\"font-weight: 400;\">. This approval follows the generic version of <\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/byetta-10-mcg-pen\"><span style=\"font-weight: 400;\">Byetta<\/span><\/a><span style=\"font-weight: 400;\"> (another GLP-1) in November. Generic liraglutide is the first once-daily generic GLP-1 injectable approved to treat Type 2 diabetes in patients 10 and older, alongside diet and exercise. It\u2019s another treatment option when <\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/victoza\/what-is\"><span style=\"font-weight: 400;\">Victoza<\/span><\/a><span style=\"font-weight: 400;\">, the brand name of liraglutide, is in short supply and GLP-1s, in general, are in great demand.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cThe FDA supports development of complex generic drugs, such as GLP-1s, by funding research and informing industry through guidance as part of our ongoing efforts to increase access to needed medications,\u201d Iilun Murphy, MD, director of the Office of Generic Drugs in the FDA\u2019s Center for Drug Evaluation and Research, said in a statement. &#8220;Generic drugs provide additional treatment options which are generally more affordable for patients. Today\u2019s approval underscores the FDA\u2019s continued commitment to advancing patient access to safe, effective, and high-quality generic drug products.\u201d<\/span><\/p>\n<h2 id=\"how-generic-victoza-works\"><span style=\"font-weight: 400;\">How generic Victoza works<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">At least <\/span><a href=\"https:\/\/www.cdc.gov\/diabetes\/about\/about-type-2-diabetes.html\"><span style=\"font-weight: 400;\">90% of the 38 million people in the U.S. with diabetes<\/span><\/a><span style=\"font-weight: 400;\"> have Type 2 diabetes, with many of them needing to use medication to help them manage their blood sugar levels.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Liraglutide works to lower blood sugar in <\/span><a href=\"https:\/\/www.victoza.com\/about-victoza-\/how-victoza--works.html\"><span style=\"font-weight: 400;\">several ways<\/span><\/a><span style=\"font-weight: 400;\">. First, it stimulates the pancreas to release more insulin when blood sugar levels are high, helping prevent the liver from producing too much sugar. This medication also slows down the process of food leaving the stomach, helping control blood sugar levels.\u00a0<\/span><\/p>\n<p><a href=\"https:\/\/www.victoza.com\/about-victoza-\/how-victoza--works.html\"><span style=\"font-weight: 400;\">Victoza<\/span><\/a><span style=\"font-weight: 400;\"> is designed to be used with diet and exercise. As a side effect of the medication, many people find that they lose weight, as it helps to curb appetite.\u00a0<\/span><\/p>\n<p><b>RELATED: <\/b><a href=\"https:\/\/www.singlecare.com\/blog\/victoza-weight-loss\/\"><b>Victoza weight loss<\/b><\/a><\/p>\n<h2 id=\"liraglutide-side-effects\"><span style=\"font-weight: 400;\">Liraglutide side effects<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">As with the name-brand version of the product, the <\/span><a href=\"https:\/\/www.singlecare.com\/blog\/victoza-side-effects\/\"><span style=\"font-weight: 400;\">potential side effects<\/span><\/a><span style=\"font-weight: 400;\"> of this generic version of liraglutide include:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Nausea<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Diarrhea<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Vomiting<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Decreased appetite<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Indigestion (dyspepsia)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Constipation<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">It can cause potentially serious complications, which may include<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Pancreatitis (inflammation of the pancreas)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Kidney impairment or kidney failure<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Hypoglycemia when used in conjunction with certain other medications, including insulin<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Acute gallbladder disease<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">The FDA also <\/span><a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-generic-once-daily-glp-1-injection-lower-blood-sugar-patients-type-2-diabetes\"><span style=\"font-weight: 400;\">cautions<\/span><\/a><span style=\"font-weight: 400;\"> that people with a personal or family history of medullary thyroid cancer (MTC) or people with multiple endocrine neoplasia syndrome Type 2 (MEN 2) should not take medications containing liraglutide. In animal studies, this medication has been found to raise the risk of thyroid C-cell tumors, but it is not known if this applies to humans.\u00a0<\/span><\/p>\n<h2 id=\"why-this-approval-matters\"><span style=\"font-weight: 400;\">Why this approval matters<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">GLP-1 medications are very effective for the treatment of Type 2 diabetes and obesity. Other medications in this class include <\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/saxenda\"><span style=\"font-weight: 400;\">Saxenda<\/span><\/a><span style=\"font-weight: 400;\"> (liraglutide), <\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/ozempic-0-25-or-0-5-mg-dose\"><span style=\"font-weight: 400;\">Ozempic<\/span><\/a><span style=\"font-weight: 400;\"> (semaglutide), <\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/wegovy\"><span style=\"font-weight: 400;\">Wegovy<\/span><\/a><span style=\"font-weight: 400;\"> (semaglutide), <\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/mounjaro\"><span style=\"font-weight: 400;\">Mounjaro<\/span><\/a><span style=\"font-weight: 400;\"> (tirzepatide), and <\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/zepbound\"><span style=\"font-weight: 400;\">Zepbound<\/span><\/a><span style=\"font-weight: 400;\"> (tirzepatide), among others. The popularity of these medications created a surge in demand, which led to <\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10338283\/\"><span style=\"font-weight: 400;\">shortages of some GLP-1 receptor agonists that began in 2022<\/span><\/a><span style=\"font-weight: 400;\">. The approval of the generic version of Victoza should help expand access for people who need this type of medication.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u201cWe are very pleased to launch liraglutide injection immediately upon receiving U.S. FDA approval, providing U.S. healthcare professionals and patients with this important generic treatment of diabetes,\u201d Dr. Bill Larkins, President of Injectables for Hikma Pharmaceuticals, said in a statement. \u201cThis launch is the latest example of our actions to expand our portfolio in growing therapeutic areas like diabetes and to provide customers and patients with affordable access to a reliable supply of high-quality essential medicines.\u201d<\/span><\/p>\n<p><b>RELATED: <\/b><a href=\"https:\/\/www.singlecare.com\/blog\/victoza-alternatives\/\"><b>Victoza alternatives<\/b><\/a><\/p>\n<h2 id=\"how-much-will-generic-victoza-cost\"><span style=\"font-weight: 400;\">How much will generic Victoza cost?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Hikma Pharmaceuticals has not announced a price for the new generic liraglutide. The<\/span><a href=\"https:\/\/www.singlecare.com\/prescription\/victoza#Price-History\"><span style=\"font-weight: 400;\"> cost of the name-brand version varies<\/span><\/a><span style=\"font-weight: 400;\">, based on pharmacy and health insurance coverage. Coupons are available for generic Victoza through SingleCare, with the lowest price averaging around $94 for the 1, 3ml of 18mg\/3ml pen of liraglutide.<\/span><\/p>\n<p><a class=\"cta-button\" href=\"https:\/\/www.singlecare.com\/prescription\/victoza\"><span style=\"font-weight: 400;\">Victoza coupons<\/span><\/a><\/p>\n<h2 id=\"when-will-generic-victoza-be-available\"><span style=\"font-weight: 400;\">When will generic Victoza be available?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Hikma Pharmaceuticals plans to make generic liraglutide available immediately in pharmacies across the U.S.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>As glucagon-like peptide-1 (GLP-1) receptor agonists continue to surge in popularity, the\u00a0U.S. Food and Drug Administration approved the second generic in this class of medications: liraglutide (Victoza). This approval follows the generic version of Byetta (another GLP-1) in November. Generic liraglutide is the first once-daily generic GLP-1 injectable approved to treat Type 2 diabetes in [&hellip;]<\/p>\n","protected":false},"author":135,"featured_media":630887,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[4114],"tags":[10298,4141,21067],"coauthors":[9482],"class_list":["post-630881","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-diabetes","tag-fda-approvals","tag-glp-1-drugs","wpautop"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA approves generic GLP-1 medication Victoza (liraglutide)<\/title>\n<meta name=\"description\" content=\"The FDA approved generic Victoza, a GLP-1 medication approved to treat Type 2 diabetes and sometimes used off-label for weight loss. Learn more about generic Victoza availability and costs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.singlecare.com\/blog\/news\/victoza-generic-approval\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA approves first generic once-daily GLP-1\" \/>\n<meta property=\"og:description\" content=\"Liraglutide is now available to treat Type 2 diabetes\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.singlecare.com\/blog\/news\/victoza-generic-approval\/\" \/>\n<meta property=\"og:site_name\" content=\"The Checkup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/singlecare\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-02T16:32:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-19T20:40:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2025\/01\/Victoza_FDA-approval_.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jennifer Larson\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"FDA approves first generic once-daily GLP-1\" \/>\n<meta name=\"twitter:description\" content=\"Liraglutide is now available to treat Type 2 diabetes\" \/>\n<meta name=\"twitter:creator\" content=\"@SingleCare\" \/>\n<meta name=\"twitter:site\" content=\"@SingleCare\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jennifer Larson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/victoza-generic-approval\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/victoza-generic-approval\\\/\"},\"author\":{\"name\":\"Heidi Borst\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#\\\/schema\\\/person\\\/fda93df2f5d09af0d250b59dfb4b46f2\"},\"headline\":\"FDA approves first generic once-daily GLP-1 medication\",\"datePublished\":\"2025-01-02T16:32:43+00:00\",\"dateModified\":\"2025-02-19T20:40:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/victoza-generic-approval\\\/\"},\"wordCount\":662,\"publisher\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/victoza-generic-approval\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Victoza_FDA-approval_.png\",\"keywords\":[\"Diabetes\",\"FDA approvals\",\"GLP-1 drugs\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/victoza-generic-approval\\\/\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/victoza-generic-approval\\\/\",\"name\":\"FDA approves generic GLP-1 medication Victoza (liraglutide)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/victoza-generic-approval\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/victoza-generic-approval\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Victoza_FDA-approval_.png\",\"datePublished\":\"2025-01-02T16:32:43+00:00\",\"dateModified\":\"2025-02-19T20:40:43+00:00\",\"description\":\"The FDA approved generic Victoza, a GLP-1 medication approved to treat Type 2 diabetes and sometimes used off-label for weight loss. Learn more about generic Victoza availability and costs.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/victoza-generic-approval\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/victoza-generic-approval\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/victoza-generic-approval\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Victoza_FDA-approval_.png\",\"contentUrl\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Victoza_FDA-approval_.png\",\"width\":1920,\"height\":1080,\"caption\":\"victoza generic - FDA approval\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/news\\\/victoza-generic-approval\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA approves first generic once-daily GLP-1 medication\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/\",\"name\":\"The Checkup, a health blog by SingleCare\",\"description\":\"Read the latest in prescription, wellness, and healthcare news\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#organization\",\"name\":\"SingleCare\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/placeholderimage-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/placeholderimage-1.jpg\",\"width\":1200,\"height\":630,\"caption\":\"SingleCare\"},\"image\":{\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/singlecare\",\"https:\\\/\\\/x.com\\\/SingleCare\",\"https:\\\/\\\/www.instagram.com\\\/singlecare\\\/?hl=en\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/singlecare\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCd9kiPIjCQw95-2BHCYePKA\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/#\\\/schema\\\/person\\\/fda93df2f5d09af0d250b59dfb4b46f2\",\"name\":\"Heidi Borst\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/54e15f256159a3a0cbbdb7480726ea326337311f82e102efe7ccf0b90b5c7cc2?s=96&d=mm&r=g5fb1f533c8ee6da65648bfe7ca214e71\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/54e15f256159a3a0cbbdb7480726ea326337311f82e102efe7ccf0b90b5c7cc2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/54e15f256159a3a0cbbdb7480726ea326337311f82e102efe7ccf0b90b5c7cc2?s=96&d=mm&r=g\",\"caption\":\"Heidi Borst\"},\"url\":\"https:\\\/\\\/www.singlecare.com\\\/blog\\\/author\\\/hborstrxsense-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"FDA approves generic GLP-1 medication Victoza (liraglutide)","description":"The FDA approved generic Victoza, a GLP-1 medication approved to treat Type 2 diabetes and sometimes used off-label for weight loss. Learn more about generic Victoza availability and costs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.singlecare.com\/blog\/news\/victoza-generic-approval\/","og_locale":"en_US","og_type":"article","og_title":"FDA approves first generic once-daily GLP-1","og_description":"Liraglutide is now available to treat Type 2 diabetes","og_url":"https:\/\/www.singlecare.com\/blog\/news\/victoza-generic-approval\/","og_site_name":"The Checkup","article_publisher":"https:\/\/www.facebook.com\/singlecare","article_published_time":"2025-01-02T16:32:43+00:00","article_modified_time":"2025-02-19T20:40:43+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2025\/01\/Victoza_FDA-approval_.png","type":"image\/png"}],"author":"Jennifer Larson","twitter_card":"summary_large_image","twitter_title":"FDA approves first generic once-daily GLP-1","twitter_description":"Liraglutide is now available to treat Type 2 diabetes","twitter_creator":"@SingleCare","twitter_site":"@SingleCare","twitter_misc":{"Written by":"Jennifer Larson","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.singlecare.com\/blog\/news\/victoza-generic-approval\/#article","isPartOf":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/victoza-generic-approval\/"},"author":{"name":"Heidi Borst","@id":"https:\/\/www.singlecare.com\/blog\/#\/schema\/person\/fda93df2f5d09af0d250b59dfb4b46f2"},"headline":"FDA approves first generic once-daily GLP-1 medication","datePublished":"2025-01-02T16:32:43+00:00","dateModified":"2025-02-19T20:40:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/victoza-generic-approval\/"},"wordCount":662,"publisher":{"@id":"https:\/\/www.singlecare.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/victoza-generic-approval\/#primaryimage"},"thumbnailUrl":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2025\/01\/Victoza_FDA-approval_.png","keywords":["Diabetes","FDA approvals","GLP-1 drugs"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.singlecare.com\/blog\/news\/victoza-generic-approval\/","url":"https:\/\/www.singlecare.com\/blog\/news\/victoza-generic-approval\/","name":"FDA approves generic GLP-1 medication Victoza (liraglutide)","isPartOf":{"@id":"https:\/\/www.singlecare.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/victoza-generic-approval\/#primaryimage"},"image":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/victoza-generic-approval\/#primaryimage"},"thumbnailUrl":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2025\/01\/Victoza_FDA-approval_.png","datePublished":"2025-01-02T16:32:43+00:00","dateModified":"2025-02-19T20:40:43+00:00","description":"The FDA approved generic Victoza, a GLP-1 medication approved to treat Type 2 diabetes and sometimes used off-label for weight loss. Learn more about generic Victoza availability and costs.","breadcrumb":{"@id":"https:\/\/www.singlecare.com\/blog\/news\/victoza-generic-approval\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.singlecare.com\/blog\/news\/victoza-generic-approval\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.singlecare.com\/blog\/news\/victoza-generic-approval\/#primaryimage","url":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2025\/01\/Victoza_FDA-approval_.png","contentUrl":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2025\/01\/Victoza_FDA-approval_.png","width":1920,"height":1080,"caption":"victoza generic - FDA approval"},{"@type":"BreadcrumbList","@id":"https:\/\/www.singlecare.com\/blog\/news\/victoza-generic-approval\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.singlecare.com\/blog\/"},{"@type":"ListItem","position":2,"name":"FDA approves first generic once-daily GLP-1 medication"}]},{"@type":"WebSite","@id":"https:\/\/www.singlecare.com\/blog\/#website","url":"https:\/\/www.singlecare.com\/blog\/","name":"The Checkup, a health blog by SingleCare","description":"Read the latest in prescription, wellness, and healthcare news","publisher":{"@id":"https:\/\/www.singlecare.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.singlecare.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.singlecare.com\/blog\/#organization","name":"SingleCare","url":"https:\/\/www.singlecare.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.singlecare.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2020\/01\/placeholderimage-1.jpg","contentUrl":"https:\/\/www.singlecare.com\/blog\/wp-content\/uploads\/2020\/01\/placeholderimage-1.jpg","width":1200,"height":630,"caption":"SingleCare"},"image":{"@id":"https:\/\/www.singlecare.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/singlecare","https:\/\/x.com\/SingleCare","https:\/\/www.instagram.com\/singlecare\/?hl=en","https:\/\/www.linkedin.com\/company\/singlecare\/","https:\/\/www.youtube.com\/channel\/UCd9kiPIjCQw95-2BHCYePKA"]},{"@type":"Person","@id":"https:\/\/www.singlecare.com\/blog\/#\/schema\/person\/fda93df2f5d09af0d250b59dfb4b46f2","name":"Heidi Borst","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/54e15f256159a3a0cbbdb7480726ea326337311f82e102efe7ccf0b90b5c7cc2?s=96&d=mm&r=g5fb1f533c8ee6da65648bfe7ca214e71","url":"https:\/\/secure.gravatar.com\/avatar\/54e15f256159a3a0cbbdb7480726ea326337311f82e102efe7ccf0b90b5c7cc2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/54e15f256159a3a0cbbdb7480726ea326337311f82e102efe7ccf0b90b5c7cc2?s=96&d=mm&r=g","caption":"Heidi Borst"},"url":"https:\/\/www.singlecare.com\/blog\/author\/hborstrxsense-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/posts\/630881","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/users\/135"}],"replies":[{"embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/comments?post=630881"}],"version-history":[{"count":0,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/posts\/630881\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/media\/630887"}],"wp:attachment":[{"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/media?parent=630881"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/categories?post=630881"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/tags?post=630881"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.singlecare.com\/blog\/wp-json\/wp\/v2\/coauthors?post=630881"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}